Factors affecting the prognosis of small hepatocellular carcinoma in Taiwanese patients following hepatic resection

Canadian Journal of Gastroenterology

Volumn 25, Issue 9, 2011, Pages 485-491

  Ko, Chih Jan ^a   Chien, Su Yu ^a   Chou, Chen Te ^a   Chen, Li Sheng ^a   Chen, Mei Ling ^a   Chen, Yao Li ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Prognosis; Small hepatocellular carcinoma; Tumour size

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTIVIRUS AGENT; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; SERUM ALBUMIN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; DISEASE FREE SURVIVAL; ETHNIC GROUP; FEMALE; FOLLOW UP; HEMIHEPATECTOMY; HEPATITIS C; HISTOLOGY; HUMAN; INJECTION; LAPAROSCOPIC SURGERY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SALVAGE THERAPY; TAIWANESE; TRANSCATHETHER CHEMOEMBOLIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 80054716565     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/790528     Document Type: Article

References (28)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43. (Pubitemid 33586866)
2. Jan CF, Chen CJ, Chen HH. Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience. J Gastroenterol Hepatol 2005;20:521-6.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
4. Cabibbo G, Craxì A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2010;14:352-5.
5. Fehér J, Lengyel G. Hepatocellular carcinoma: Occurrence, risk factors, biomarkers. Orv Hetil 2010;151:933-40.
6. Chen THH, Chen CJ, Yen MF, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002;98:257-61.
7. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417-22.
8. Zhou XD, Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001;91:1479-86.
9. Yamamoto M, Takasaki K, Otsubo T, et al. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Ann Surg 2004;239:395-9. (Pubitemid 38229070)
10. Ochiai T, Sonoyama T, Ichikawa D, et al. Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol 2004;130:197-202. (Pubitemid 38553627)
11. Nathan H, Schulick RD, Choti MA, et al. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 2009;249:799-805.
12. American Joint Committee on Cancer. Comparison Guide: Cancer Staging Manual. Fifth versus Sixth Edition. 〈www.cancerstaging.org/products/ ajccguide.pdf〉 (Accessed on July 12, 2011).
13. Riley TR, Bhatti A. Preventative strategies in chronic liver disease: Part II. cirrhosis. Am Fam Phys 2001;64:1735-41.
14. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000;127:603-8.
15. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005;11:1086-92. (Pubitemid 41341758)
16. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999;19:329-38.
17. Lu XY, Xi T, Lau WY, et al. Pathobiological features of small hepatocellular carcinoma: Correlation between tumor size and biological behavior. J Cancer Res Clin Oncol 2011;137:567-75.
18. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-24. (Pubitemid 34183954)
19. Fuster J, Garcia-Valdecasas JC, Grande L, et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996;223:297-302. (Pubitemid 26086722)
20. Franco D, Capussotti L, Smadja C, et al. Resection of hepatocellular carcinomas: Results in 72 European patients with cirrhosis. Gastroenterology 1990;98:733-8. (Pubitemid 20069712)
21. Nanashima A, Tobinaga S, Masuda J, et al. Selecting treatment for hepatocellular carcinoma based on the results of hepatic resection and local ablation therapy. J Surg Oncol 2010;101:481-5.
22. Tanaka S, Noguchi N, Ochiai T, et al. Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting Milan criteria: Rationale for partial hepatectomy as first strategy. J Am Coll Surg 2007;204:1-6. (Pubitemid 44960045)
23. Hwang S, Lee SG, Moon DB, et al. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl 2007;13:741-6. (Pubitemid 46796546)
24. Sasaki Y, Yamada T, Tanaka H. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma. Ann Surg 2006;244:771-80. (Pubitemid 44629952)
25. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24. (Pubitemid 30456545)
26. Wang ZL, Liang P, Dong BW, Yu XL, Yu de J. Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: A retrospective study. J Gastrointest Surg 2008;12:327-37.
27. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation. Ann Surg 2002;235:373-82. (Pubitemid 34183888)
28. Cabibbo G, Latteri F, Antonucci M, Craxì A. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol 2009;6:159-69.